Literature DB >> 22433829

Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

A Brodbelt1.   

Abstract

Advances in imaging, including multivoxel spectroscopy, tractography, functional MRI and positron emission spectroscopy, are being used by neurosurgeons to target aggressive areas in gliomas, and to help identify tumour boundaries, functional areas and tracts. Neuro-oncological surgeons need to understand these techniques to help maximise tumour resection, while minimising morbidity in an attempt to improve the quality of patient outcome. This article reviews the evidence for the practical use of multimodal imaging in modern glioma surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22433829      PMCID: PMC3473906          DOI: 10.1259/bjr/19282704

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  40 in total

1.  Functional MRI for presurgical planning: problems, artefacts, and solution strategies.

Authors:  T Krings; M H Reinges; S Erberich; S Kemeny; V Rohde; U Spetzger; M Korinth; K Willmes; J M Gilsbach; A Thron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

2.  Pseudo-reorganization of language cortical function at fMR imaging: a consequence of tumor-induced neurovascular uncoupling.

Authors:  John L Ulmer; Hendrikus G Krouwer; Wade M Mueller; M Sahin Ugurel; Mehmet Kocak; Leighton P Mark
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

3.  Language functional magnetic resonance imaging in preoperative assessment of language areas: correlation with direct cortical stimulation.

Authors:  Franck-Emmanuel Roux; Kader Boulanouar; Jean-Albert Lotterie; Mehdi Mejdoubi; James P LeSage; Isabelle Berry
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

Review 4.  White matter functional connectivity as an additional landmark for dominant temporal lobectomy.

Authors:  H Duffau; M Thiebaut de Schotten; E Mandonnet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05       Impact factor: 10.154

5.  Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence.

Authors:  Tracy R McKnight; Mary H von dem Bussche; Daniel B Vigneron; Ying Lu; Mitchel S Berger; Michael W McDermott; William P Dillon; Edward E Graves; Andrea Pirzkall; Sarah J Nelson
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

6.  Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.

Authors:  D Croteau; L Scarpace; D Hearshen; J Gutierrez; J L Fisher; J P Rock; T Mikkelsen
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

Review 7.  Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.

Authors:  G E Keles; K R Lamborn; M S Berger
Journal:  J Neurosurg       Date:  2001-11       Impact factor: 5.115

8.  Preoperative mapping of cortical language areas in adult brain tumour patients using PET and individual non-normalised SPM analyses.

Authors:  Philipp T Meyer; Laszlo Sturz; Mathias Schreckenberger; Uwe Spetzger; Georg F Meyer; Keyvan S Setani; Osama Sabri; Udalrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-14       Impact factor: 9.236

9.  Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy.

Authors:  G Evren Keles; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Mitchel S Berger
Journal:  J Neurosurg       Date:  2004-01       Impact factor: 5.115

10.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Authors:  Edward R Laws; Ian F Parney; Wei Huang; Fred Anderson; Angel M Morris; Anthony Asher; Kevin O Lillehei; Mark Bernstein; Henry Brem; Andrew Sloan; Mitchel S Berger; Susan Chang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

View more
  6 in total

Review 1.  Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

Authors:  C von Neubeck; A Seidlitz; H H Kitzler; B Beuthien-Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-07-10       Impact factor: 3.039

2.  Evolving Use of fMRI in Medicare Beneficiaries.

Authors:  S Asnafi; R Duszak; J M Hemingway; D R Hughes; J W Allen
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-08       Impact factor: 3.825

Review 3.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

Review 4.  Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients.

Authors:  John H Rossmeisl; Paulo A Garcia; Gregory B Daniel; John Daniel Bourland; Waldemar Debinski; Nikolaos Dervisis; Shawna Klahn
Journal:  Vet Radiol Ultrasound       Date:  2013-11-13       Impact factor: 1.363

5.  Diagnostic challenges, management and outcomes of midline low-grade gliomas.

Authors:  Mueez Waqar; Shahid Hanif; Nitika Rathi; Kumar Das; Rasheed Zakaria; Andrew R Brodbelt; Carol Walker; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

6.  A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging.

Authors:  Bo Gao; Xudong Shen; Mark S Shiroishi; Mingfan Pang; Zhiqian Li; Benxia Yu; Guiquan Shen
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.